Skip to Main Content
Close
Who We Serve
Overview
Researchers
Authors
Reviewers
Healthcare Professionals
Patients & Their Supporters
Librarians
Health Sciences Industry
Societies
Agents & Distributors
What We Offer
Overview
Subject Areas
Journals
Books & Book Series
Collections
Courses
Podcasts
Open Access
What We Solve
Overview
Accessing Knowledge
Presenting Knowledge
Applying Knowledge
About Us
Publish with Us
Overview
Publish Your Paper
Calls for Papers
Open Access Publishing
Publication Services
Partner Publications
Publication Ethics
Resources for You
Overview
Experience Karger
The Waiting Room
Embarrassing Problems
Nephrology Viewpoints
ISCN Online
DermaCompass
Search Dropdown Menu
header search
search input
Search input auto suggest
filter your search
All Content
All Journals
Acta Haematologica
Search
Advanced Search
User Tools Dropdown
Register
Login
Toggle Menu
Menu
Content
Articles
Issues
Online First
Early View
About
Details
Contact
Editorial Board
Guidelines
Subscription Rates
Rights & Permissions
Advertising
Submission
Skip Nav Destination
Issues
Select Decade
2020
2010
2000
1990
1980
1970
1960
1950
1940
Select Year
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Issue
March - Volume 113, Issue 2, Pages 97 - 154
April - Volume 113, Issue 3, Pages 155 - 212
June - Volume 113, Issue 4, Pages 213 - 267
June - Volume 114, Issue 1, Pages 1 - 70
August - Volume 114, Issue 2, Pages 71 - 126
September - Volume 114, Issue Suppl. 1, Pages 1 - 32
October - Volume 114, Issue 3, Pages 127 - 182
November - Volume 114, Issue 4, Pages 183 - 266
Volume 114, Issue Suppl. 1
September 2005
ISSN 0001-5792
EISSN 1421-9662
Close navigation menu
In this Issue
Special Section
Paper
Issue Navigation
Search within issue:
Search within issue
Acta Haematologica 2005, Vol. 114, Suppl. 1
Special Section
Paper
All Issues
Email alerts
Online First Alert
Latest Issue Alert
Close Modal
Latest
Most Read
Most Cited
Chronic lymphocytic leukemia: disease biology
:
The biology of chronic lymphocytic leukemia
Cladribine, Cytarabine, And Etoposide (CCE)-Based Regimens Are Safe and Tolerable In Relapsed And Refractory AML Patients
Bortezomib and Vorinostat Therapy as Maintenance Therapy Post Autologous Transplant for Non-Hodgkin’s Lymphoma Using R-BEAM or BEAM Transplant Conditioning Regimen
Prognostic Markers in the Era of Targeted Therapies
:
Prognostic Markers in CLL
RSS
Current Issue RSS Feed
Open Issues RSS Feed
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal